Meet Applied UV at the Benzinga Reopening Stocks Summit this Month

Since the beginning of 2020, the importance of healthcare has been at the forefront of minds around the globe. And disinfecting every surface, and even ourselves, remains paramount to the safety of all.

Since the beginning of 2020, the importance of healthcare has been at the forefront of minds around the globe. And disinfecting every surface, and even ourselves, remains paramount to the safety of all. So, it’s exciting to learn that companies like Applied UV, Inc. (NASDAQ:AUVI) are acquiring and using technologies that prevent infections in the healthcare market and hospitality and commercial markets. 

The interesting part is that they use cutting-edge narrow-range light (UVC) to automatically, safely and completely destroy pathogens that can make you ill.

With the world opening up, it’s more important than ever to ensure businesses and healthcare facilities have the best sanitation systems available to keep people safe. 

The fact is, recovery could be just around the corner, and you don’t want to miss the investment ride. Come to the Benzinga Reopening Stocks Summit on August 18-19, presented by Rocket Mortgage, and discover what leaders think about the current and future market climate. The COO and CFO of Applied UV, Inc. will be there along with other companies to give you information that could help you hit the recovery ground running. 

Find out what they and others have to say by registering now for your seat.

Total
0
Shares
Related Posts
Read More

AstraZeneca And Merck Announced Results From The Final Analysis Of Overall Survival From Phase 3 Propel Trial Of Lynparza Plus Abiraterone And Prednisone Or Prednisolone (Abi/Pred), Compared To Placebo Plus Abi/Pred. Did Not Reach Statistical Significa…

Median OS was 42.1 months for the LYNPARZA plus abi/pred arm versus 34.7 months for the placebo plus abi/pred arm, representing a 7.4-month absolute difference in median OS versus a standard of care

AZN